CRO Services Center (Phase IV)

Phase 4 trials, also known as a post-approval studies, post-marketing surveillance trials, or real-world evidence (RWE) studies, are generally conducted after a Phase 3 trial is complete and a drug has received regulatory approval.

In a Phase 4 trial, side effects are studied over time in users of the drug after it has become commercially available. These trials allow the drug to be studied in a real-world population, which can be much more diverse and inclusive than the patients who took part in a Phase 3 clinical trial. The tools and technologies required for a Phase 4 trial are similar to those used in a Phase 3 trial. The conduct of these trials can also be managed by a CRO.

How can we help?

Looking for help with your Phase IV project? If you're searching for information or a supplier, let Clinical Leader lend you a hand.

Submit A Question

CRO Services Center (Phase IV) Provider - Catalyst Clinical Research
Catalyst Clinical Research

Catalyst Clinical Research is a clinical development organization providing highly customizable solutions to the global biopharmaceutical industry. Built from more than two decades of listening to their customers, devising customer-centric solutions and helping them breakthrough with clinical development programs surrounded by therapeutically aligned teams of experts.


CRO Services Center (Phase IV) Provider - Ciox Life Sciences
Ciox Life Sciences

Clinical data is fragmented across the healthcare ecosystem. Working at the intersection of clinical data, artificial intelligence, and medical research, we facilitate the advancement of patient care by accessing medical records to support clinical investigations. Ciox neutrally utilizes its ubiquitous access to medical records regardless of provider systems, therapeutic areas, care settings, or IT systems. The result is a full patient picture for your research while preserving lineage and protecting patient privacy.


CRO Services Center (Phase IV) Provider - Cytel

Now more than ever, the clinical development path is full of make-or-break data complexities and analytical challenges. As a pioneer in evidence generation, with deep expertise in advanced analytical solutions, we are uniquely equipped to unlock the value from increasingly complex data. Life Sciences companies count on Cytel to deliver exceptional insight, minimize trial risk and accelerate the development of promising new medicines that improve human life.


Have questions about selecting the right Phase IV service provider?

The Clinical Leader team can help. We'll match your needs with the right companies.

Contact us via email for assistance.

CRO Services Center (Phase IV) Provider - inSeption Group
inSeption Group

inSeption distinguishes people as the most impactful variable in the outsourcing equation. Our path-breaking model attracts biopharma companies who demand a partner that shares in their drive to conduct impeccable development and will provide quality and dependable clinical solutions. We offer full outsourcing, consulting services, and functional service provider (FSP) solutions.


CRO Services Center (Phase IV) Provider - IQVIA Biotech
IQVIA Biotech

IQVIA Biotech delivers flexible clinical development solutions designed to help biotech and emerging biopharma companies get treatments to patients. When you partner with our clinical team, you gain expertise from two decades of running clinical trials exclusively for biotech companies. We understand the unique challenges, hurdles, and opportunities you face. From strategy and trial design to execution, we draw on this experience to put together the right solution for you.


CRO Services Center (Phase IV) Provider - Medidata Acorn AI
Medidata Acorn AI

Medidata Acorn AI is a Medidata company that represents the next horizon of the industry leader’s 20-year mission of powering smarter treatments and healthier people. Acorn AI is designed to make data liquid across the entire lifecycle and to answer the most important questions in R&D and commercialization for customers. Built upon the Medidata platform comprising more than 20,000 trials and 5 million patients, Acorn AI products feature one of the industry’s largest structured, standardized clinical trial data repository connected with real world, translational and other datasets.


CRO Services Center (Phase IV) Provider - OCT Clinical
OCT Clinical

OCT is the leading contract research organization in Russia. Since 2005, OCT’s team has conducted over 300 clinical trials in 29 therapeutic areas in Eastern Europe and the CIS region. Our team of 150+ clinical professionals provides a full range of high-quality CRO services for Phase I-IV and BE studies, with therapeutic expertise in oncology, infectious disease, and all major therapeutic indications.

CRO Services Center (Phase IV) Provider - PAREXEL

Parexel is in the business of improving the world’s health. We do this by providing a suite of biopharmaceutical services that help clients across the globe transform scientific discoveries into new treatments. From clinical trials to regulatory, consulting, and market access, our therapeutic, technical, and functional ability is underpinned by a deep conviction in what we do.

CRO Services Center (Phase IV) Provider - Precision ADVANCE
Precision ADVANCE

Precision ADVANCE is a collection of interconnected services and complementary teams uniquely focus on the complexities of clinical, regulatory, manufacturing, and commercial needs to successfully bring cell or gene therapies to market. Learn more about how we accelerate clinical development with Precision for Medicine, optimize next-gen manufacturing with Project Farma and drive commercial success with Precision Value & Health.


CRO Services Center (Phase IV) Provider - Premier Research
Premier Research

Premier Research recognizes that when an emerging biotech is built around a single asset, focus and flexibility are critical to success. And, since many of our customers require additional infrastructure, we fill in resourcing gaps to help their product reach the patient faster. We are a mid-size CRO and offer strategies that are customized for each program, with tailored processes designed to meet highly specific needs.

CRO Services Center (Phase I-III) Provider - QPS

QPS is an award winning, global, full service contract research organization (CRO) delivering the highest quality of discovery, preclinical, and clinical drug development services across the US, Europe and Asia. QPS is known for proven quality standards, technical expertise, a flexible approach to research, client satisfaction, wholly owned Phase I clinical sites and turnkey laboratories and facilities. QPS stands tall in its commitment to delivering superior quality, skilled performance and trusted service to its valued customers.


CRO Services Center (Phase IV) Provider - United BioSource - UBC
United BioSource - UBC

United BioSource LLC (UBC) is a leading provider of pharmaceutical support services, partnering with life science companies to make medicine and medical products safer and more accessible. UBC is well known for our expertise in generating authoritative, real-world evidence of product effectiveness, safety, and value to assist healthcare decisions and enhance patient care.


CRO Services Center (Phase IV) Provider - Worldeide Clinical Trials
Worldwide Clinical Trials

Founded by physicians committed to advancing medical science, Worldwide is out to change how the world experiences CROs – in the best possible way. From early phase and bioanalytical sciences through late phase, post-approval and real-world evidence, we provide world-class, full-service drug development services across a range of therapeutic areas, including central nervous system, cardiovascular, metabolic, general medicine, oncology and rare diseases. We never compromise on science or safety. We’re never satisfied with the status quo. We’re the Cure for the Common CRO.